Background: Giant cell arteritis (GCA) is a systemic vasculitis that preferentially targets medium-sized and large arteries. The etiopathogenesis of the syndrome is not known, and because of the paucity of information concerning the mechanisms of blood vessel wall damage, treatment options are limited. Clues to pathogenic events in this arteritis may derive from understanding the function of tissue-infiltrating cells. Arterial injury in GCA is associated with the formation of granulomas that are composed of T cells, activated macrophages, and multinucleated giant cells. To examine the role of T cells, we implanted inflamed temporal arteries from patients with GCA into severe combined immunodeficiency (SCID) mice and studied whether the vascular lesions were T cell-dependent. Materials and Methods: Temporal artery specimens from patients with GCA were engrafted into SCID mice. The histomorphologic appearance of fresh arteries and grafts retrieved from the mice was compared by twocolor immunohistochemistry, and the functional profile of tissue-infiltrating cells was analyzed by semiquantifying cytokine transcription with a polymerase chain reaction (PCR)-based assay system. The repertoire of tissueinfiltrating T cells was assessed for the presence of dominant T cell populations by using T cell receptor (3-chain-specific PCR followed by sequencing. To inves-
tigate the role of T cells in the activation of tissue-infiltrating macrophages, T cells were depleted from the arterial grafts by treating the mice with T cell-specific antibodies and the production of monokines was monitored. To demonstrate the disease relevance of T cells expanding in the implants, T fells were isolated from tissue segments and adoptively transferred into mice implanted with syngeneic arteries. The in situ production of lymphokines was then detennined. Results: The inflammatory infiltrate penetrating all layers of the arterial wall persisted in the xenotransplants, indicating that the inflammatory foci represent independent functional units. Similar quantities of T cell-and macrophage-derived cytokines were detected in fresh and engrafted tissue. However, the diversity of tissueinfiltrating T cells decreased following implantation. T cells with identical T cell receptors were expanded in different mice that had been engrafted with tissue fragments from the same patient, indicating that T cell survival in the arterial wall was a nonrandom process. To confirm the disease relevance of these T cells, T cell depletion and reconstitution experiments were performed. Antibody-mediated elimination of T cells from the xenotransplants resulted in the attenuation of the production of the monokines, IL-1,B and IL-6. Adoptive transfer of syngeneic tissue-derived T cells, but not of peripheral blood T cells, into engrafted SCID mice enhanced the transcription of IL-2 and IFN-,y in the implanted arteries. Conclusions: The vascular lesions of GCA are maintained in human artery-mouse chimeras, indicating that all cellular and noncellular components necessary for the disease are present in the temporal artery. Activation of tissue-infiltrating T cells and macrophages depends upon an infrequent subpopulation of lesional T cells that have a survival advantage in the xenotransplants. The selective proliferation of these T cells in the arteries suggests that there is recognition of a locally expressed antigen. Therefore, these T cells should be candidate targets for the development of novel therapeutic strategies in GCA.
INTRODUCTION
Giant cell arteritis (GCA) is an inflammatory disease of medium-sized and large arteries. Injury to the arterial wall is caused by inflammatory infiltrates composed of T lymphocytes and macro-phages. Most patients have involvement of the proximal branches of the aorta, which possess well-defined internal and external elastic laminae. Morbidity and mortality are related to ischemic events such as blindness and stroke and to aneurysm formation (1, 2) . Inflammatory lesions in the vessel wall are often granulomatous and may include multinucleated giant cells (3) . The cellular infiltrate of the arteries is generally centered on the medial layer with extension into the intima and adventitia and consists mainly of lymphocytes, histiocytes, macrophages, and infrequently, plasma cells. Multinucleated giant cells are often close to the fragmented internal elastic lamina or are located circumferentially along the destroyed elastic membrane.
Nonrandomness of incidence rates in different geographic regions and in different ethnic groups has been attributed to genetic factors contributing to disease pathogenesis. Female dominance among patients, a stringent restriction in age at disease onset, and tissue tropism may also be surrogates for genetic risk factors. Thus far, convincing experimental data have only been presented for one genetic system, the HLA-DR alleles (4, 5) . GCA is an HLA-associated disease with about 60% of patients expressing an allelic variant of the HLA-DR4 family. Sequence comparison of HLA-DR alleles in patients with biopsy-proven disease has demonstrated a sharedsequence polymorphism mapping to the floor of the antigen-binding site of the HLA-DR molecule (6, 7) . Amino acid positions 9, 28, and 30 of the HLA-DRB 1 gene are strongly associated with GCA. All three amino acid positions contribute to binding pockets that accommodate side chains of an antigenic peptide bound in the HLA-DR molecule (8, 9) . These data provide evidence for an important role of antigen-binding in the pathogenesis of GCA.
The evidence for a pivotal role of T cells recognizing an antigen in the inflammatory lesion has so far been indirect. It has been described that selected CD4+ T cells undergo clonal proliferation in the tissue (10) . Clonally expanded T cell specificities with identical T cell receptor (TCR) 1-chain sequences are present at distinct and independent inflammatory foci, suggesting that a single antigen recruits T cells to the wall of the inflamed arteries. However, the distribution and the nature of such an antigen remains unresolved. Possibilities include an arterial antigen that is locally expressed and gains immunogenicity, or an exogenous antigen that is deposited in the arterial wall. The concept of GCA as an antigen-driven immune response has been emphasized by studies analyzing the local production of cytokines (1 1). Cytokine mRNA could be detected in extracts from temporal arteries harvested from patients with GCA but not in tissue samples collected from patients with unrelated disease. Production of mRNA for interleukin-l( (IL-1,B) , IL-6, and transforming growth factor-,Bl (TGF-,B1) could be assigned to activated macrophages, and tissue-infiltrating T cells were shown to synthesize IL-2 and interferon-y (IFN-y) but rarely IL-4 or IL-5 mRNA. Lymphokine-secreting T cells represent a minority of the total T cell infiltrate and accumulate in the adventitia, suggesting the recognition of an adventitial antigen (12) .
To allow for definite conclusions on the role of T cells in the vasculitic inflammation, we have established an animal model of the GCA. Temporal artery specimens from affected patients were engrafted into severe combined immunodeficiency (SCID) mice. These mice have defects in humoral as well as cell mediated immunity and can therefore serve as recipients for xenogeneic grafts (13, 14) . In these GCA-SCID mouse chimeras, the arteritis persists, indicating that the inflamed arterial wall represents a functionally independent unit. The inflammatory response is dependent upon a small subpopulation of T cells that displays a limited TCR repertoire and has a survival advantage in the tissue. Depletion of these T cells abrogates the synthesis of the proinflammatory monokines, IL-1,B and IL-6. After adoptive transfer, these T cells home to the implanted tissue where they promote increased production of IL-2 and IFN-,y.
MATERIALS AND METHODS

Patients and Tissue Samples
Temporal artery biopsy specimens were obtained from patients undergoing biopsies for diagnostic reasons. All specimens showed inflammatory infiltrates establishing the diagnosis of GCA. Tissue specimens of 1-1.5 cm in length were cut into 3 to 5 equal pieces. One piece was embedded in OCT compound (Lab Tech Products, Naperville, IL) for subsequent immunohistochemical staining. The nonsaturating conditions. Denatured amplified products were dot-blotted onto supported nitrocellulose membranes (Biorad Laboratories, Hercules, CA), prehybridized at 550C for 3 to 5 hr, and then hybridized with biotinylated internal probes (200 ng/ml) (Biotin-On Phosphoramidite, Clontech Laboratories, Palo Alto, CA) at 42°C (,B-actin-and all cytokine specific-probes except for IL-113) or 55°C (TCR Ca-and IL-1,-specific probes) overnight. The sequences of the probes are in Table 1 . Membranes were washed once in 2X SSC 0.1% SDS at 420C for 10 min and once at 55°C in 2X SSC 0.1% SDS for 5 min. The second washing step was omitted for the IL-2-and IFN-,y-specific probes. Membranes were then blocked with blocking buffer (Boehringer Mannheim, Indianapolis, IN) for 30 min and incubated with streptavidin-alkaline phosphatase (Dako). The membranes were developed by a color reaction using 5-bromo-4-chloro-3-indolyl phosphate and 4-nitro blue tetrazolium chloride (Boehringer Mannheim) and the optical density of the dots was scanned with an AMBIS Optical Imaging System (Scanalytics, Ballerica, MA). The copy numbers of cytokine-specific cDNA sequences in the tissue extracts were determined by comparison to the standard curve. Results are expressed for adjusted tissue as copy number per 200,000 /3-actin sequences.
T Cell Receptor-4 Gene Sequence Analysis cDNA from implanted and nonimplanted tissue specimens were adjusted for TCR-AC gene transcripts and amplified with BV2, BV5S2, BV8, BV1 3S1, BVI7, or BV18 specific primers and a BC primer (15) . Because of the limited amount of cDNA available, approximately 30% of the total TCR repertoire was analyzed. The BV-specific primers were arbitrarily chosen. Radioactive amplified products were separated on 5% polyacrylamide sequencing gels and exposed on autoradiographic film. Dominant bands defined as containing at least 30% of the total amplification product and exceeding the sum of the neighboring bands were identified, eluted from the gel, and directly sequenced by using a modification of the genomic amplification with the transcript sequencing approach described by Stoflet et al. (16, 17) . Adoptive Transfer Experiments Mice were implanted with temporal artery specimens as described above. After 4 weeks, the tissue was retrieved, placed into tissue culture wells in the presence of RPMI-1640 supplemented with 10% FCS (Hyclone Laboratories, Logan, UT), 200 ,M L-glutamine, penicillin/streptomycin (500 U/ml and 5 mg/ml, respectively) (Life Technologies), and recombinant human IL-2 (20 U/ml, Cetus Immune Corporation, Emeryville, CA). In parallel, a T cell line from peripheral blood mononuclear cells (PBMC) was established by polyclonal activation with immobilized anti-CD3 (OKT3, ATCC, Rockville, MD) and cultured in IL-2 containing medium. Then 5 x 106 T cells were adoptively transferred into SCID mice implanted with temporal artery tissues. To avoid an alloreactive reaction, temporal artery specimens and T cell lines from the identical patient were used. The tissue was retrieved 5 days after the adoptive transfer and analyzed for in situ cytokine transcription by semiquantitative PCR.
T Cell Proliferative Assays T cell lines were established from tissue specimens explanted from SCID mice by incubation of the tissue fragment in IL-2 containing medium. T cells were harvested, washed in IL-2-free medium to deplete exogenous IL-2, and restimulated in 96-well round-bottomed culture plates at a concentration of 5 (18, 19) . To document that the overall histomorphology of the arterial wall was maintained, the smooth muscle cells of the medial layer were identified with antismooth muscle actin antibodies (Fig. lA) . Tissueinfiltrating T cells were present in all samples (Fig. IB) and included CD4+ and CD8+ subsets ( Fig. 1 C, D) . Macrophages survived in the grafts and were identified with anti-CD68 antibodies (Fig. 1E) .
Proliferating cells were identifed by staining for the cell cycle-dependent Ki-67 antigen to provide evidence of cell replenishment in the implanted arterial tissue (20) . As shown in Fig. IF , actively dividing cells, including T lymphocytes, were present in all layers of the engrafted temporal artery specimen. Inspection of the tissue sections indicated that the number of T cells in the tissue had decreased after 4-6 weeks of implantation. To quantify the T cell infiltrate in the grafts, nonimplanted and recovered tissue samples were compared for the density of the T cell infiltrate. Data are given in Table 2 and show that T cell recovery after implantation ranged between 31% and 115%. In 4 of the 5 tissues analyzed, T cell numbers decreased by 40-70%. Thus a substantial fraction of the tissue-residing T cells either died in the tissue or emigrated (p = 0.08). Concomitantly, a portion of the retained T cells proliferated and replenished the T cell infiltrate.
In summary, these experiments demonstrated that the arteritis persisted despite disruption of cell influx from the circulation and was maintained by self-replenishment of tissue-infiltrating cells. The inflamed arterial wall obviously represents an independent functional unit.
Production of Inflammatory Cytokines Continues in Xenotransplants with Vasculitic Lesions
To address the question as to whether the nature of the inflammatory response changed after xenotransplantation and separation from potentially important extra-arterial sources, the patterns Previous work has shown that GCA is characterized by a defined cytokine pattern expressed in the tissue (1 1). Accumulated T cells synthesize IL-2 and IFN-,y mRNA and macrophages transcribe IL-13, IL-6, and TGF-11 mRNA. Comparative studies for these cytokines in nonimplanted and retrieved tissues from eight patients are summarized in Fig. 2 . As shown in Fig. 2A , copy numbers for TCR-AC gene transcripts were essentially unaltered although T cell numbers declined, suggesting that the remaining T cells were activated and expressed higher amounts of TCR transcripts on a per-cell basis. In line with this interpretation is the fact that the production of IL-2 and IFN-,y mRNA persisted in the implanted tissue ( Fig. 2A) (Fig. 2B) . These data suggest that no fundamental change occurred in the inflammatory process when the inflamed arteries were isolated and engrafted for [4] [5] [6] weeks. The persistence of the disease-typical inflammation provides a unique opportunity to study disease mechanisms in GCA.
Diversity of the TCR Repertoire in Vasculitic Lesions
Tissue-infiltrating T cells in GCA are highly diverse. Isolation of IL-2-responsive infiltrating CD4+ T cells and sequencing of their TCR molecules have provided evidence that a small fraction of these T cells are functionally distinct in that they undergo clonal proliferation at the site of pathology (10) . We have therefore proposed that T cells with potential disease relevance are infrequent. Functional properties and recruitment mechanisms of T cells that do not recognize antigen in the infiltrate are unknown, but these T cells most likely represent bystander T cells. We wanted to address the question as to whether T cell loss affected the T cell repertoire randomly or whether certain T cell specificities had a survival advantage in the engrafted tissue. To estimate the diversity of the TCR repertoire, TCR sequences from six arbitrarily selected BV gene families (BV2, BV5S2, BV8, BV13S1, BV17, and BV18) encompassing approximately 30% of the total repertoire were analyzed for the representation of different size classes. Nonimplanted and explanted tissue samples from four patients were compared. Adjusted cDNA was amplified with BV-BC-specific primer sets. Amplified products were radioactively labeled and size-fractionated on polyacrylamide gels. Representative examples are given in Fig. 3 . Each band represents TCR sequences sharing a particular length of the third Cytokine expression in fresh temporal artery specimens from GCA patients and in specimens explanted after 4 weeks Biopsy specimens from eight GCA patients were cut into small fragments and either shock frozen or implanted into C.B.-17 SCID mice. Paired samples were analyzed in parallel. Total RNA was extracted, cDNA was adjusted for the number of ,B-actin copies, and cytokine sequences were semiquantified by PCR and subsequent oligonucleotide hybridization. Results are expressed as number of copies per 200,000 f3-actin copies.
(A) T cell-derived cytokines; (B) macrophage-derived cytokines.
complementarity determining region (CDR3).
The reduction in the number of bands after tissue implantation indicated a reduction in the diversity of the TCR repertoire. Xenotransplantation induced a shift in the composition of the tissueinfiltrating T cell population. Not Fig. 4 . In situ production of IFN-,y mRNA decreased within 2 days after antibody-mediated T cell depletion. In situ production of IL-1i3 mRNA also subsided, however, the decline was delayed and followed the disappearance of IFN-,y mRNA production. These data are consistent with the interpretation that IL-1,B mRNA production in the vasculitic lesions is T cell-dependent.
To directly demonstrate the disease relevance of tissue-infiltrating T cells, T cell lines were established from tissue retrieved from GCA-SCID mouse chimeras. Tissue-derived T cells were then adoptively transferred into mice implanted with autologous temporal artery tissue. As controls, T cell lines established from the peripheral blood of the same patient were transferred into the GCA-SCID mouse chimeras. The xenografts were retrieved 5 days after the adoptive transfer and the in situ transcription of lymphokines was determined. Results from experiments examining tissue and T cells from two 
"TCR sequence was also found in the pre-implanted tissue, albeit at a lower frequency. kii previous studies, we have described a topographical relationship between IFN-,y-producing T cells and IL-i13/IL-6-producing macrophages in the adventitia. The experiments in the chimera model now conclusively demonstrate that activation of these tissue-residing macrophages is T cell-dependent. Depletion of human T cells by a T cell-specific antiserum in the GCA-SCID mouse chimeras suppressed the in situ production of IL-I83. IL-If3 transcription was not completely abrogated, but it is likely that the low level of IL-IO transcription in the tissue was maintained by few residual T cells producing IFN-,y and not by a T cell-independent activation mechanism.
Equally important is the observation that tissue-infiltrating T cells are functionally diverse and that they either disappear or undergo clonal proliferation in the implanted tissue. After 4-6 weeks, lesional T cells had declined to 60% of preimplantation levels ( Table 2 ). The finding that the production of IL-2 and IFN-,y mRNA persisted already indicated that T cells with the ability to produce these cytokines were enriched (Fig. 2) . The fraction of T cells disappearing from the arterial segment is probably even higher but the proliferative activity of the retained T cells replenishes the infiltrate. Evidence for this model came from a shift in the TCR repertoire. The T cells infiltrating the temporal artery 4 weeks after implantation were less diverse, as shown by the loss of complexity in CDR3 size classes (Fig. 3) . More importantly, certain clonal T cell populations had gained dominance and could be identified. Selection of these clonotypes was not a random process. Rather, identical TCR sequences emerged in independent tissue fragments implanted into different mice (Table 3 ). The plausible explanation for this finding is that a shared antigen expressed throughout the blood vessel wall is recognized by a small repertoire of T cells, thereby inducing clonal expansion of these specificities. The functional relevance of such T cells for the vasculitic inflammation could be documented in adoptive transfer experiments. In these experiments, the injection of T cells that had accumulated in the grafts into a GCA-SCID mouse chimera resulted in increased production of IL-2 and IFN-,y mRNA in the engrafted temporal artery tissue. These experiments cannot completely exclude the possibility that a murine blood-derived antigen is recognized in the human tissue. However, IFN-,y production in the implanted tissue (22) . Clonal expansion of some T cells was a consistent finding in all patients analyzed. Again, a subset of clonally proliferating T cell specificities was detected in distinct regions of the artery. Utilizing these different strategies, we have so far collected information on a total of 17 patients with GCA. The repertoire of T cells recruited for antigen recognition in the arterial wall of these 17 patients was not restricted except that BV5S2-BJ2S3 T cell clones were encountered using all three approaches. This contrasts with the restriction in the expression of HLA-DR molecules in the patient group. A possible interpretation of these findings is that the TCR repertoire is sufficiently plastic to allow different individuals to recruit distinct T cells for antigen recognition in the disease process. This would imply that the restriction in the molecular TCR structure of disease-inducing T cells found in some of the animal models is not generalizable (25) (26) (27) (28) .
Several lines of indirect evidence have suggested that the vasculitic inflammation in GCA is an antigen-driven process, although the distribution and the nature of the putative antigen are unknown. Short of a demonstration of the antigen, the experiments in the GCA-SCID mouse chimera provide the most direct support for a pivotal role of antigen recognition in the pathogenesis of the vasculitic inflammation. Data presented here also indicate that the antigen is localized in the arterial tissue and that sufficient amounts of antigen are available in the engrafted tissue for at least [4] [5] [6] weeks to maintain the inflammation and to activate adoptively transferred T cells. These findings are best compatible with the model that an arterial self-antigen gains T cell stimulatory capacity in GCA patients. However, a persisting exogenous antigen cannot be completely excluded. To identify the antigen, T cell clonotypes selected in the xenotransplant might be the most powerful reagent since their proliferative activity should depend solely on the presence of the relevant antigen and the appropriate antigen-presenting cells.
